Pharmaron Beijing: Riding CRO Surge as Pharma Sector Rebounds
Pharmaron Beijing thrives as China’s pharma sector rebounds—leveraging booming CRO demand, strong earnings from WuXi AppTec, and defensive ETF inflows to boost future growth potential.
4 minutes to read

